Stock ALGETA ASA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Algeta ASA Other OTC

Equities

NO0010239437

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Algeta ASA
2014 Actavis : Factbox - M&A frenzy transforming global pharma RE
2014 Actavis : M&A frenzy in healthcare sector RE

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Actavis : Factbox - M&A frenzy transforming global pharma
RE
Actavis : M&A frenzy in healthcare sector
RE
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo
RE
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta
RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid
RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid
RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
RE
Bayer AG : Bayer says does not want to provide details on Algeta offer
RE
Algeta ASA : Algeta to host Capital Markets Days
PU
Algeta ASA : CORRECTION: Algeta ASA : Algeta Results for the Third Quarter 2013
PU
Algeta ASA : Algeta's Financial Calendar 2014
PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences
PU
Algeta ASA : Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call
PU
Algeta ASA : New data and analyses from the phase III ALSYMPCA trial of radium Ra 223 dichloride to be presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013
PU
Algeta ASA : Algeta results for the First Half and Second Quarter 2013
PU
Algeta ASA : Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer
PU
Algeta ASA : Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call
PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences
PU
Algeta ASA : Algeta celebrates the official opening of its commercial production facility for Xofigo® (radium Ra 223 dichloride) at the Institute for Energy Technology (IFE) in Norway
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALGETA Stock
  4. Stock
  5. News Algeta ASA